Gadotti VM - Search Results

1

The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain.

Defaye M, Iftinca MC, Gadotti VM, Basso L, Abdullah NS, Cuménal M, Agosti F, Hassan A, Flynn R, Martin J, Soubeyre V, Poulen G, Lonjon N, Vachiery-Lahaye F, Bauchet L, Mery PF, Bourinet E, Zamponi GW, Altier C. Defaye M, et al. Among authors: gadotti vm. J Clin Invest. 2022 Jun 15;132(12):e154317. doi: 10.1172/JCI154317. J Clin Invest. 2022. PMID: 35608912 Free PMC article.

2

Depressive-like behaviour of mice lacking cellular prion protein.

Gadotti VM, Bonfield SP, Zamponi GW. Gadotti VM, et al. Behav Brain Res. 2012 Feb 14;227(2):319-23. doi: 10.1016/j.bbr.2011.03.012. Epub 2011 Mar 23. Behav Brain Res. 2012. PMID: 21439331

3

Cellular prion protein protects from inflammatory and neuropathic pain.

Gadotti VM, Zamponi GW. Gadotti VM, et al. Mol Pain. 2011 Aug 16;7:59. doi: 10.1186/1744-8069-7-59. Mol Pain. 2011. PMID: 21843375 Free PMC article.

4

Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.

You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. You H, et al. Among authors: gadotti vm. Mol Pain. 2011 Nov 17;7:89. doi: 10.1186/1744-8069-7-89. Mol Pain. 2011. PMID: 22093952 Free PMC article.

5

Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.

Gadotti VM, You H, Petrov RR, Berger ND, Diaz P, Zamponi GW. Gadotti VM, et al. Mol Pain. 2013 Jul 1;9:32. doi: 10.1186/1744-8069-9-32. Mol Pain. 2013. PMID: 23815854 Free PMC article.

6

TMEM16C cuts pain no SLACK.

Gadotti VM, Zamponi GW. Gadotti VM, et al. Nat Neurosci. 2013 Sep;16(9):1165-6. doi: 10.1038/nn.3497. Nat Neurosci. 2013. PMID: 23982447 No abstract available.

7

1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.

Bladen C, Gadotti VM, Gündüz MG, Berger ND, Şimşek R, Şafak C, Zamponi GW. Bladen C, et al. Among authors: gadotti vm. Pflugers Arch. 2015 Jun;467(6):1237-47. doi: 10.1007/s00424-014-1566-3. Epub 2014 Jul 3. Pflugers Arch. 2015. PMID: 24990197

8

The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.

García-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, Deage M, François A, Bourinet E, Zamponi GW. García-Caballero A, et al. Among authors: gadotti vm. Neuron. 2014 Sep 3;83(5):1144-58. doi: 10.1016/j.neuron.2014.07.036. Neuron. 2014. PMID: 25189210 Free article.

9

Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.

Bladen C, McDaniel SW, Gadotti VM, Petrov RR, Berger ND, Diaz P, Zamponi GW. Bladen C, et al. Among authors: gadotti vm. ACS Chem Neurosci. 2015 Feb 18;6(2):277-87. doi: 10.1021/cn500206a. Epub 2014 Nov 5. ACS Chem Neurosci. 2015. PMID: 25314588 Free PMC article.

10

NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.

Berger ND, Gadotti VM, Petrov RR, Chapman K, Diaz P, Zamponi GW. Berger ND, et al. Among authors: gadotti vm. Mol Pain. 2014 Dec 6;10:77. doi: 10.1186/1744-8069-10-77. Mol Pain. 2014. PMID: 25481027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters